Deena Kuruvilla, MD

Deena Kuruvilla, MD
Neurology
Accepting new patients? Yes
Referrals required? From physicians only
Patient type treated: Adult

Deena E. Kuruvilla, MD, is a neurologist who specializes in headache disorders, including chronic migraine and cluster headaches. “People don’t realize that headaches are one of the most common causes of disability worldwide, and one of the top reasons patients go to the emergency room,” she says. “Our ultimate goal is to break their headaches and give them relief so they can participate happily in their everyday lives.”

Many patients also don’t realize how many options are available to them. Dr. Kuruvilla regularly provides relief for severe headache and facial pain using such treatments as nerve block injections, botulinum toxin injections, sphenopalatine ganglion blockade and trigger point injections, as well as intravenous infusion therapies. She is an expert in such alternative and complementary treatments as vitamin therapy for patients who may not tolerate prescribed medications; and devices such as supra orbital nerve stimulators, which can help those who have tried all other treatments without success.

“I personally want to be a pioneer in the area of headaches, and participate in clinical trials and bring patients treatments that are new and upcoming and can basically give them a much better quality of life,” Dr. Kuruvilla says. An assistant professor in neurology at Yale School of Medicine, she focuses her research on alternative headache medicine, resource utilization in migraine patients and neuroimaging in headache disorders. Dr. Kuruvilla is chair of the complementary and alternative medicine section of the American Headache Society.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.